Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed August 9, 2026.
Parkinsons Progression Markers Initiative Ppmi is a company within the Medical Research category. The Parkinson's Progression Markers Initiative (PPMI) is a comprehensive, international study that collects robust, real-time, open-access data to accelerate breakthroughs in understanding Parkinson's disease. It involves thousands of volunteers, including those with and without Parkinson's, and provides data for researchers globally.
Parkinsons Progression Markers Initiative Ppmi was founded in 2010.
Parkinsons Progression Markers Initiative Ppmi is rated Emerging on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Parkinsons Progression Markers Initiative Ppmi is Strong.
AI models classify Parkinsons Progression Markers Initiative Ppmi as a Challenger. AI names competitors first.
Parkinsons Progression Markers Initiative Ppmi appeared in 3 of 3 sampled buyer-intent queries (100%). The brand's mission, offerings, and call for participation are highly discoverable through direct and related queries, especially given the emphasis on 'open access data' and 'volunteers'.
PPMI is widely perceived as a groundbreaking and critical initiative in Parkinson's research, known for its extensive data collection, global collaboration, and commitment to open science to accelerate discoveries and validate findings. Key gap: No key discrepancies are present within the provided text. All information aligns to a clear understanding of PPMI's purpose.
Of 5 key facts verified about Parkinsons Progression Markers Initiative Ppmi, 5 are well-documented (likely accurate across AI models), 0 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
The success and impact of PPMI heavily rely on continuous participant recruitment and retention, ongoing funding, and the effective utilization of its open-access data by the wider scientific community to translate findings into clinical advancements.
Buyers turn to Parkinsons Progression Markers Initiative Ppmi for Individual Lab-Specific Studies: Researchers conducting smaller-scale, often siloed studies on Parkinson's progression markers, with limited standardization and data sharing across institutions., Contract Research Organizations (CROs) for Clinical Trials: CROs manage drug trials, which collect data, but typically for specific therapeutic interventions rather than broad, open-access biomarker d, Fragmented Research: Without a coordinating effort like PPMI, research into Parkinson's progression markers would likely remain less integrated, slower, and potentially redundant, hindering the pace o, among 3 documented problem areas.
Buyers evaluating Parkinsons Progression Markers Initiative Ppmi typically ask AI models about "Parkinson's progression markers initiative", "PPMI data access", "volunteer Parkinson's study", and 1 similar queries.
Parkinsons Progression Markers Initiative Ppmi's core products are Longitudinal clinical, imaging, and biological data from Parkinson's patients and controls; an open-access data portal; research publications and presentations..
Parkinsons Progression Markers Initiative Ppmi uses Open access for data (implied non-profit/grant-funded initiative)..
Parkinsons Progression Markers Initiative Ppmi serves Parkinson's researchers, pharmaceutical companies, academic institutions, clinicians, individuals with Parkinson's disease or risk factors, and the wider scientific community..
Parkinsons Progression Markers Initiative Ppmi Its large-scale, international, longitudinal design, comprehensive data collection across diverse cohorts (including prodromal), and a commitment to real-time, open-access data sharing to accelerate research breakthroughs.
Brand Authority Index (BAI) tier: Emerging (exact score locked for unclaimed brands)
Archetype: Challenger
Official website: https://ppmi-info.org/
Last analyzed: August 9, 2026
Founded: 2010 (source: official website)
Headquarters: Not explicitly stated (affiliated with Michael J. Fox Foundation) (source: official website)
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile